Cupboard with medicines in drugstore

The New Reality for OTC: Why Packaging Has Become a Strategic Growth Engine

The New Reality for OTC: Why Packaging Has Become a Strategic Growth Engine

For decades, secondary packaging in consumer healthcare was primarily viewed as a functional necessity: protecting products, carrying mandatory information, and ensuring regulatory compliance. In today’s over-the-counter (OTC) market, however, packaging has taken on a much broader role. It has become a critical brand asset, a sustainability statement, and an increasingly important tool for consumer engagement. 

This shift is being driven by profound changes in the consumer health sector: Behavioral, technological, and economic changes are reshaping how consumers manage their health and how brands create value. What appears to be a stable market is in reality entering a more competitive and rapidly evolving phase. 

For OTC brands, this presents both an opportunity and a challenge. As consumers become more health-empowered, more digital, and more environmentally aware, secondary packaging is emerging as one of the few touchpoints that can simultaneously influence purchase decisions, strengthen trust, support compliance, and advance circularity.

The OTC Market Continues to Expand 

Europe’s OTC market continues to benefit from powerful underlying trends. Increasing self-care, aging populations, growing health awareness, and pressure on healthcare systems are all contributing to sustained market growth. Emerging categories like stress, sleep, gut health, GLP-1 side-effect management and women’s health reflect a deep behavioral shift towards prevention and self-management. 

This creates an environment in which OTC products play an increasingly important role in improving access to care while reducing pressure on physicians and healthcare budgets.  

Perhaps surprisingly, only 10-16% of the growth is coming from recently launched product innovations, highlighting the industry’s continued reliance on established brands. 

This places significant importance on brand differentiation. In categories crowded with familiar products and established competitors, packaging often becomes the most visible expression of innovation. 

Additionally, Rx-to-OTC switches have already become an important source of market value.  Products that were originally prescription medicines before switching to OTC status generated approximately €1.4 billion in European OTC sales and accounted for 42% of sales among leading non-prescription brands. Eight of Europe’s top twenty OTC brands originated as prescription medicines.

For packaging, this trend has important implications. Newly switched products must establish consumer trust quickly, often addressing more complex treatment categories than traditional OTC products. Secondary packaging therefore becomes a critical communication platform, helping consumers understand indications, usage instructions, safety information, and brand credentials at the point of purchase. 

Winning Consumer Attention in an Omnichannel World 

The traditional pharmacy shelf remains important, but the consumer journey increasingly begins elsewhere. OTC shoppers move seamlessly between channels and expect a consistent experience wherever they engage with a brand — they research symptoms on social media, discuss treatments in online forums or use AI-powered search tools before ever entering a pharmacy. At the same time, e-commerce continues to gain share across consumer health categories. 

This changes the role of packaging dramatically. 

Today’s pack must work in multiple environments:  

  • On a pharmacy shelf 
  • As a thumbnail image in an online marketplace 
  • In social media content 
  • In AI-driven product recommendations 
  • During product use and disposal 

Secondary packaging has effectively become an omnichannel communication platform that connects physical and digital experiences.

Why Paperboard Packaging is Well Positioned to Win 

As OTC brands navigate this new environment, paperboard secondary packaging offers a unique combination of benefits. 

From a branding perspective, paperboard packaging delivers innovative structural possibilities, excellent print quality, strong shelf visibility, and ample space for consumer communication. It enables brands to highlight product benefits, communicate trust, and create visual differentiation in increasingly crowded markets. 

At the same time, packaging circularity expectations continue to rise among both consumers and regulators.

The recently adopted EU Packaging and Packaging Waste Regulation (PPWR) establishes a harmonized framework for packaging across the European Union and will require all packaging to be designed for recycling while encouraging waste reduction and packaging reuse. 

The regulation is being introduced in response to growing environmental concerns. According to the European Commission, packaging waste in Europe reached approximately 186.5 kg per person in 2022, while packaging accounts for around 50% of the paper used and 40% of the plastics consumed within the EU. 

For healthcare and OTC companies, paperboard packaging offers several advantages aligned with these objectives: 

  • High recycling rates of 87%  
  • Well-established collection infrastructure 
  • Made from primarily renewable raw materials  
  • Offers opportunities for packaging optimization and material reduction 

Increasingly, packaging circularity is no longer a separate consideration. It is becoming an integrated component of brand value and consumer trust. 

A Strategic Asset for the Next Phase of Consumer Health 

The OTC sector is entering a period of transformation. Self-care is expanding, Rx-to-OTC switching is opening new opportunities, consumers are becoming more digitally empowered, and packaging circularity requirements are accelerating across Europe. 

In this environment, secondary packaging can no longer be viewed simply as a compliance requirement. 

It is simultaneously a brand ambassador, a trust-building tool, an educational platform and a key enabler of consumer choice. 

For OTC brands seeking growth in Europe’s next phase of consumer health, paperboard secondary packaging is uniquely positioned to deliver on all of these expectations, helping products stand out on the shelf, succeed online, comply with emerging regulation and build lasting consumer confidence. 

To discuss how we can help with your next Healthcare packaging project, contact us and a member of the Healthcare team will get in touch.

References:

consumer-healths-next-phase-iqvia-consumer-health.pdf

Rx to OTC switch in Europe is not just about viability. It’s about trust. | IQVIA